Tumor Liquid Biopsy Platform

Integrated platform for cancer diagnosis utilizing liquid biopsy techniques with CRISPR/Cas9 technology. Includes complete workflow from sample collection through DNA sequencing to result analysis.

Circulating tumor DNA detection and analysis system for cancer diagnosis and monitoring. Enables early cancer detection through blood-based liquid biopsy technology with high sensitivity and specificity.

An independently developed liquid biopsy platform for detecting circulating tumor cells with high sensitivity and specificity. This non-invasive blood-based test provides comprehensive tumor-related information for malignant tumor diagnosis and treatment guidance.

An independently developed platform for detecting circulating tumor DNA with high sensitivity and specificity compared to traditional detection methods. This liquid biopsy approach enables non-invasive, painless diagnosis through a single blood sample for comprehensive cancer patient support.

Multi-biomarker screening solution for early-stage cancer identification. Analyzes blood samples to detect cancer-associated molecular signatures. Facilitates timely clinical intervention and improved patient outcomes.

Advanced genetic testing platform for cancer diagnosis and personalized medicine applications. The system has been validated across thousands of real-world clinical scenarios for reliability and accuracy.

Integrated platform for advanced biomarker analysis supporting early disease detection, risk stratification, and prognostic assessment across cardiometabolic, liver, cardiovascular, and brain health conditions.

An integrated biochemistry testing platform for clinical laboratory diagnostics. The system encompasses multiple biochemical assays approved for clinical use in patient sample analysis.

Molecular diagnostics platform for nucleic acid detection and amplification-based testing. Enables identification of pathogens and genetic markers for infectious disease and other molecular-based diagnoses.

Liquid biopsy platform designed to detect and analyze circulating tumor cells in patient samples. Enables non-invasive cancer monitoring and personalized medicine applications through advanced genetic testing.

Integrated diagnostic platform combining genomic sequencing with molecular analysis for precision medicine applications. Enables personalized treatment planning and early disease detection.

Molecular analysis system for detection of nucleic acids and genetic material. Enables identification of pathogens, genetic mutations, and infectious agents at molecular level.